Spectrum Pharmaceutecals Inc (SPPI)

[dcaf7]

Just published, "Poziotinib in Treatment-Naïve Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-label Phase 2 Trial (Cohort 4)" by many authors including Heymach, Lebel and Socinski.
Good article. A lot of positive data but at the end you can find "The ZENITH20 study was terminated due to an FDA decision".
https://www.jto.org/article/S1556-0864(23)00199-5/fulltext